Balan Biomedical announced today the appointment of Mr. Michael F. Pyszczek to the position of Vice President of Technology. His primary responsibilities will include development of strategic goals and initiatives for the Balan engineering division. “We are pleased to bring a scientist of Mike’s caliber to the Balan team” said Elisabeth Hager, MD, Chairman and CEO of Balan.

Mr. Pyszczek has a Bachelor’s degree in Chemistry and an MS in business management. He has served the corporate research departments of Honeywell and Greatbatch Inc. as a senior scientist. While at Greatbatch, he also led the new product development group of the Electrochemical Battery Division, and the chemical manufacturing department for the medical product group. He previously held the position of Director of Power Source Development for GentCorp Ltd. Mr. Pyszczek has been granted 12 US patents and has published over 20 papers in the fields of electrochemistry and power source design.

Balan Biomedical Inc. has moved its headquarters to the Lennox Technology Enterprise Center (TEC), located at 150 Lucius Gordon Drive, in West Henrietta, NY. “We are excited to be among the innovative companies collocated at the Lennox Tech Center,” said Elisabeth Hager, MD, Chairman and CEO of Balan. “Our mission is to provide high quality transdisciplinary information to optimize decision support for new product development in the medical device and consumer health industries. Being closer to the users and sources of that information supports our business model.”

Balan Biomedical Inc. announced the  launch two new networks for Medical Professionals and Patients. The Networks provide Balan with access to first hand experience of the users and referrers of medical devices and other health care products. “Bringing the voice of the user to the idea generation and product design phase of new product development allows medical device and consumer health product companies to fulfill unmet clinical needs,” said Elisabeth Hager, MD, Chairman and CEO of Balan Biomedical. “Medical professionals, who decide which products to use or recommend, and patients, who depend on those products, are consulted early in the process. More complete information means better decisions for healthcare companies and better outcomes for healthcare providers and consumers.”

Balan Biomedical Inc. was launched today through incorporation in the State of New York. “Balan offers medical device and consumer health companies a method for gathering essential but previously unavailable information to make better decisions regarding new product development,” said Elisabeth Hager, MD Chairman and CEO of Balan. “By tapping our networks of patients and medical professionals in concert with our proprietary analytics capability, device and consumer health companies can develop truly innovative products, further differentiating them in the marketplace.”